Elanco Animal Health, Inc. (ELAN) reported Tuesday a net loss of $276 million or $0.56 per share for the fourth quarter, sharply wider than $8 million or $0.02 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter was $0.13 per share, compared to $0.14 per share in the year-ago quarter.
Total revenues for the quarter grew 12 percent to $1.14 billion from $1.02 billion in the same quarter last year. Organic constant currency revenue growth was 9 percent.
For the first quarter, the company expects adjusted earnings in a range of $0.33 to $0.36 per share on revenues between $1.280 billion and $1.305 billion, with organic constant currency revenue growth of 4 to 6 percent. Looking ahead to fiscal 2026, the company now projects adjusted earnings in a range of $1.00 to $1.06 per share on revenues between $4.95 billion and $5.02 billion, with organic constant currency revenue growth of 4 to 6 percent.
In Tuesday's pre-market trading, ELAN is trading on the NYSE at $24.46, down $0.29 or 1.15 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.